The National Institute for Health and Care Excellence (NICE) and Scottish Medicines Consortium (SMC) make recommendations to inform public reimbursement of healthcare technologies based on their clinical- and cost-effectiveness in England and Scotland, respectively. Some companies choose not to make a submission resulting in a terminated appraisal and non-reimbursement. This research aims to systematically analyse all NICE and SMC terminated appraisals.
Authors: Richard Macaulay, Andrea Berardi, Ikhlaas Kasli
To find out more about this poster you can register to download it here after the ISPOR event.